Summer 2026

Marketing Operations & Analytics Intern

Posted on 2/9/2026

Prolaio

Prolaio

51-200 employees

Real-time cardiovascular care analytics platform

Compensation Overview

$25/hr

Chicago, IL, USA

In Person

Relocation and housing stipends not offered for this internship.

Category
Data & Analytics (1)
Required Skills
Hubspot
Excel/Numbers/Sheets
Google Analytics
Requirements
  • The candidate must be working toward a degree in Marketing, Analytics, Business, or a related field.
  • Must have strong comfort with spreadsheets (Google Sheets or Excel) and be able to use advanced formulas.
  • Must have familiarity and comfort with basic marketing metrics such as funnels, conversion rates, attribution, and UTMs.
  • Must be able to work with messy datasets and improve data quality, being detail-oriented and consistent.
  • Must be a clear communicator who can document processes and explain findings simply.
  • Experience with or willingness to learn HubSpot, GA4, Looker Studio, and Smartsheet quickly.
Responsibilities
  • Support marketing data cleanup and organization including naming conventions, deduping, source tracking, and lifecycle consistency.
  • Build and maintain weekly and monthly reporting and dashboards tied to funnel performance and recruitment key performance indicators.
  • Document workflows and create templates and checklists to make recurring processes more efficient.
  • Identify and implement at least one process improvement that reduces manual effort.
  • Assist with content execution and performance tracking as needed.

Prolaio provides a cardiovascular-focused health tech platform that helps healthcare providers improve patient outcomes through real-time data analytics and continuous monitoring. It collects data from electronic health records, patient surveys, and wearable sensors to build predictive models that warn care teams about potential health issues before they become critical. Healthcare providers access the platform via a subscription, giving them real-time analytics, alerts, and evidence-based care planning tools to monitor patients and optimize treatments. The company differentiates itself by concentrating on cardiovascular care and enabling continuous learning, patient engagement, and collaboration with pharmaceutical companies and research institutions to support new therapies. The overall goal is to reduce hospital admissions and readmissions while delivering timely, data-driven care that keeps patients healthier.

Company Size

51-200

Company Stage

Early VC

Total Funding

$25.5M

Headquarters

Scottsdale, Arizona

Founded

2022

Simplify Jobs

Simplify's Take

What believers are saying

  • Kardigan acquisition integrates Prolaio's data platform with cardiac intelligence.
  • Supports all-remote heart studies generating high-density CV insights.
  • Curates largest CV dataset to prevent avoidable heart events.

What critics are saying

  • Data incompatibility with Kardigan's R&D systems erodes value in 12-18 months.
  • FDA scrutiny halts platform use in trials and triggers fines in 6-12 months.
  • Key personnel loss stalls analytics updates in 3-6 months.

What makes Prolaio unique

  • Prolaio's FDA-cleared software integrates real-world CV data with proprietary algorithms.
  • Comprehensive patient kit includes wrist monitor, smart cuff, scale, and ECG patches.
  • Tech-enabled trial enrichment optimizes CV study design and boosts statistical power.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Prolaio who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

401(k) Retirement Plan

401(k) Company Match

Performance Bonus

Stock Options

Company Equity

Retirement Plan: 401(k) plan

Paid Time Off

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

7%

2 year growth

0%
Business Wire
Mar 28th, 2025
Kardigan Acquires Prolaio to Create a Pioneering Heart Health Company with One-of-a-Kind Integrated Cardiovascular Data and Therapeutics Platform

Kardigan, a heart health company modernizing cardiovascular (CV) drug development, announced today that it has acquired Prolaio, a clinical intelligence comp...

Securities and Exchange Commission
Sep 13th, 2023
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

INACTIVE